New drug CagriSema leads to 14% weight loss in trial
Share on PinterestNew combo drug from Novo Nordisk leads to more weight loss than semaglutide alone, according to late-stage trial...
CagriSema
Novo Nordisk A/S: CagriSema demonstrated superior HbA1c
CagriSema achieved superior weight loss of up to 14.2%, where up to 43% of the people achieved ≥15% weight loss...
